People news

Share this article:
AstraZeneca named Rich Fante president of the company's US business. Fante will replace Tony Zook, who was recently named president of MedImmune, in addition to his position as CEO of AstraZeneca North America and head of global marketing. Fante was previously vice president, brand strategy & portfolio operations, and led marketing efforts for all AstraZeneca brands in the US.
 
Contract-sales firm PDI has appointed Nancy Lurker as CEO and member of the company's board of directors, effective Nov. 18. Lurker was previously senior vice president and CMO for Novartis Pharmaceuticals Corp., where she launched several products including Exforge, Tekturna, Reclast and the Exelon Patch.
Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.